{
  "id": 12047,
  "url": "https://www.jmir.org/2026/1/e92647",
  "title": "At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study",
  "summary": "Background: Depression, anxiety, and posttraumatic stress disorder (PTSD) are leading global causes of disability. Standard interventions have slow mechanisms of action, high attrition, and significant accessibility barriers. While intravenous and intranasal ketamine are rapid-acting alternatives, high cost and intensive logistical requirements limit adoption. Sublingual at-home ketamine addresses some gaps but is constrained by low bioavailability and variable absorption. Subcutaneous administr",
  "authors": "Acacia C Parks, Amanda L Woodward, Robert D Henry, Kristin A Arden, Leonardo Vando, Jack Swain, Bishal Lamichhane",
  "category": "research",
  "topics": "healthcare",
  "orgs": null,
  "regions": "us",
  "published_at": "2026-07-20T20:15:02.000Z",
  "fetched_at": "2026-07-21T05:10:12.656Z",
  "source_slug": "x-jmir-journal-of-medical-internet-researc",
  "source_name": "JMIR (Journal of Medical Internet Research)",
  "source_homepage": "https://www.jmir.org",
  "ethics_ai_record_url": "https://ethics.ai/record/12047",
  "original_url": "https://www.jmir.org/2026/1/e92647",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}